These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23756163)
1. Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma. Littera R; Zamboni F; Tondolo V; Fantola G; Chessa L; Orrù N; Sanna M; Valentini D; Cappai L; Mulargia M; Caocci G; Arras M; Floris A; Orrù S; La Nasa G; Carcassi C Hum Immunol; 2013 Oct; 74(10):1288-94. PubMed ID: 23756163 [TBL] [Abstract][Full Text] [Related]
2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408 [TBL] [Abstract][Full Text] [Related]
3. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma. Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. López-Vázquez A; Rodrigo L; Martínez-Borra J; Pérez R; Rodríguez M; Fdez-Morera JL; Fuentes D; Rodríguez-Rodero S; Gonzáez S; López-Larrea C J Infect Dis; 2005 Jul; 192(1):162-5. PubMed ID: 15942906 [TBL] [Abstract][Full Text] [Related]
5. KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians. Yindom LM; Mendy M; Bodimeade C; Chambion C; Aka P; Whittle HC; Rowland-Jones SL; Walton R PLoS One; 2017; 12(11):e0188307. PubMed ID: 29149205 [TBL] [Abstract][Full Text] [Related]
6. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population. Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377 [TBL] [Abstract][Full Text] [Related]
7. A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation. Buhler S; Giostra E; Gbame C; de Rham C; Mullhaupt B; Dufour JF; Majno P; Negro F; Bochud PY; Villard J; Liver Int; 2016 Sep; 36(9):1331-9. PubMed ID: 26717049 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation. Golden-Mason L Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413 [No Abstract] [Full Text] [Related]
9. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995 [TBL] [Abstract][Full Text] [Related]
10. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia. Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis virus infection affects DNA methylation in mice with humanized livers. Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133 [TBL] [Abstract][Full Text] [Related]
12. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C. Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398 [TBL] [Abstract][Full Text] [Related]
13. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Paladino N; Flores AC; Marcos CY; Fainboim H; Theiler G; Arruvito L; Williams F; Middleton D; Fainboim L Tissue Antigens; 2007 Apr; 69 Suppl 1():109-11. PubMed ID: 17445180 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype. Sobecks RM; Askar M; Thomas D; Rybicki L; Kalaycio M; Dean R; Avery R; Mossad S; Copelan E; Bolwell BJ Exp Clin Transplant; 2011 Feb; 9(1):7-13. PubMed ID: 21605017 [TBL] [Abstract][Full Text] [Related]
15. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a. Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501 [TBL] [Abstract][Full Text] [Related]
16. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042 [TBL] [Abstract][Full Text] [Related]
17. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Leone N; Rizzetto M Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144 [TBL] [Abstract][Full Text] [Related]
18. Chimpanzee susceptibility to hepatitis C virus infection correlates with presence of Pt-KIR3DS2 and Pt-KIR2DL9: paired activating and inhibitory natural killer cell receptors. Abi-Rached L; Guethlein LA; Norman PJ; Parham P Immunogenetics; 2015 Oct; 67(10):625-8. PubMed ID: 26260270 [TBL] [Abstract][Full Text] [Related]
19. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363 [TBL] [Abstract][Full Text] [Related]
20. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection. Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]